136 related articles for article (PubMed ID: 30501188)
21. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Bassi DE; Mahloogi H; Klein-Szanto AJ
Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
[TBL] [Abstract][Full Text] [Related]
22. miR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway.
Kang S; Zhao Y; Hu K; Xu C; Wang L; Liu J; Yao A; Zhang H; Cao F
Prostate; 2014 Aug; 74(11):1095-106. PubMed ID: 24913567
[TBL] [Abstract][Full Text] [Related]
23. Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4.
Creemers JW; Groot Kormelink PJ; Roebroek AJ; Nakayama K; Van de Ven WJ
FEBS Lett; 1993 Dec; 336(1):65-9. PubMed ID: 8262218
[TBL] [Abstract][Full Text] [Related]
24. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
[TBL] [Abstract][Full Text] [Related]
25. Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.
Goswami R; Mukherjee S; Ghadiyaram C; Wohlfahrt G; Sistla RK; Nagaraj J; Satyam LK; Subbarao K; Palakurthy RK; Gopinath S; Krishnamurthy NR; Ikonen T; Moilanen A; Subramanya HS; Kallio P; Ramachandra M
Bioorg Med Chem; 2014 Jun; 22(12):3187-203. PubMed ID: 24794746
[TBL] [Abstract][Full Text] [Related]
26. Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide Ac-[d-Leu]LLLRVK-Amba in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Quantification.
Sauter M; Haag J; Bay C; Leuschner F; Haefeli WE; Kuhn TC; Burhenne J
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140086
[TBL] [Abstract][Full Text] [Related]
27. PACE4 regulates apoptosis in human pancreatic cancer Panc‑1 cells via the mitochondrial signaling pathway.
Tian XF; Huang GM; Zang HL; Cao H
Mol Med Rep; 2016 Dec; 14(6):5205-5210. PubMed ID: 27779720
[TBL] [Abstract][Full Text] [Related]
28. PACE4-altCT isoform of proprotein convertase PACE4 as tissue and plasmatic biomarker for prostate cancer.
Couture F; Wang L; Dufour F; Chabot-Maheux K; Ekindi Ndongo N; Sabbagh R; Day R
Sci Rep; 2022 Apr; 12(1):6066. PubMed ID: 35410344
[TBL] [Abstract][Full Text] [Related]
29. Subtilisin-like proprotein convertase paired basic amino acid-cleaving enzyme 4 is required for chondrogenic differentiation in ATDC5 cells.
Yuasa K; Futamatsu G; Kawano T; Muroshita M; Kageyama Y; Taichi H; Ishikawa H; Nagahama M; Matsuda Y; Tsuji A
FEBS J; 2012 Nov; 279(21):3997-4009. PubMed ID: 22925071
[TBL] [Abstract][Full Text] [Related]
30. PACE4: a subtilisin-like endoprotease with unique properties.
Mains RE; Berard CA; Denault JB; Zhou A; Johnson RC; Leduc R
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):587-93. PubMed ID: 9032441
[TBL] [Abstract][Full Text] [Related]
31. [Structure and properties of proprotein convertase inhibitors].
Kibirev VK; Osadchuk TV
Ukr Biokhim Zh (1999); 2012; 84(2):5-29. PubMed ID: 22642118
[TBL] [Abstract][Full Text] [Related]
32. The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).
Kara I; Poggi M; Bonardo B; Govers R; Landrier JF; Tian S; Leibiger I; Day R; Creemers JW; Peiretti F
J Biol Chem; 2015 Jan; 290(5):2812-21. PubMed ID: 25527501
[TBL] [Abstract][Full Text] [Related]
33. Engineering of α1-antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis.
Hada K; Isshiki K; Matsuda S; Yuasa K; Tsuji A
Protein Eng Des Sel; 2013 Feb; 26(2):123-31. PubMed ID: 23155057
[TBL] [Abstract][Full Text] [Related]
34. Genomic organization and alternative splicing of human PACE4 (SPC4), kexin-like processing endoprotease.
Tsuji A; Hine C; Tamai Y; Yonemoto K; Mori K; Yoshida S; Bando M; Sakai E; Mori K; Akamatsu T; Matsuda Y
J Biochem; 1997 Aug; 122(2):438-52. PubMed ID: 9378725
[TBL] [Abstract][Full Text] [Related]
35. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases.
Van de Ven WJ; Roebroek AJ; Van Duijnhoven HL
Crit Rev Oncog; 1993; 4(2):115-36. PubMed ID: 8420571
[TBL] [Abstract][Full Text] [Related]
36. Enhancing the Drug-Like Profile of a Potent Peptide PACE4 Inhibitor by the Formation of a Host-Guest Inclusion Complex with β-Cyclodextrin.
Navals P; Kwiatkowska A; Mekdad N; Couture F; Desjardins R; Day R; Dory YL
Mol Pharm; 2023 Sep; 20(9):4559-4573. PubMed ID: 37555521
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship studies of dipeptide-based hepsin inhibitors with Arg bioisosteres.
Kwon H; Ha H; Jeon H; Jang J; Son SH; Lee K; Park SK; Byun Y
Bioorg Chem; 2021 Feb; 107():104521. PubMed ID: 33334587
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer.
Mekdad N; Tran TMH; Desjardins R; Kwiatkowska A; Couture F; Day R
Sci Rep; 2022 Oct; 12(1):17489. PubMed ID: 36261691
[TBL] [Abstract][Full Text] [Related]
39. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.
Lissitzky JC; Luis J; Munzer JS; Benjannet S; Parat F; Chrétien M; Marvaldi J; Seidah NG
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):133-8. PubMed ID: 10657249
[TBL] [Abstract][Full Text] [Related]
40. The proprotein convertases and their implication in sterol and/or lipid metabolism.
Seidah NG; Khatib AM; Prat A
Biol Chem; 2006 Jul; 387(7):871-7. PubMed ID: 16913836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
